Hypothesis: The Leukemias—Proliferative or Accumulative?

Author:

BIERMAN HOWARD R.12

Affiliation:

1. Institute for Cancer and Blood Research, Beverly Hills, California.

2. Institute for Cancer and Blood Research, Beverly Hills, Calif.; Clinical Professor of Medicine, Loma Linda University, and Cedars Division, Cedars Sinai Medical Center, Los Angeles, Calif.

Abstract

Abstract Contrary to the traditional concept, in many instances the leukemias are characterized by an essentially normal or slower individual leukocyte generation time, impaired maturation, altered cell release into the circulation, and prolonged survival of the "leukemic" cell, resulting in a progressive accretion of the potentially divisible cell population arrested in intermediary phases of development. We have come to a critical reorientation in our thinking of the leukemias and neoplasia in general. Continued expansion along conventional lines might be profitably complemented by another program aimed at correction of the leukemic process by encouraging maturation without cellular destruction. The significance of this moment is the inevitable realization that the dream of a cell specific "magic bullet" which would jam the metabolic machinery of the "leukemic cell" may instead correct that defective mechanism by aiding the leukocyte to mature properly. Efforts to accelerate or correct the altered maturation may offer additional approaches to the treatment of the leukemias with or without conventional chemotherapy. A reevaluation of the leukemias and possibly other neoplasms as disorders primarily of accumulation rather than proliferation may be a useful working hypothesis to encourage newer therapeutic approaches.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3